NO304024B1 - Nye mono- og bicykliske DNA-gyraseinhibitorer - Google Patents

Nye mono- og bicykliske DNA-gyraseinhibitorer

Info

Publication number
NO304024B1
NO304024B1 NO951210A NO951210A NO304024B1 NO 304024 B1 NO304024 B1 NO 304024B1 NO 951210 A NO951210 A NO 951210A NO 951210 A NO951210 A NO 951210A NO 304024 B1 NO304024 B1 NO 304024B1
Authority
NO
Norway
Prior art keywords
dna gyrase
gyrase inhibitors
novel mono
bicyclic dna
bicyclic
Prior art date
Application number
NO951210A
Other languages
English (en)
Norwegian (no)
Other versions
NO951210D0 (no
NO951210L (no
Inventor
J Rgen Geiwiz
Tschi Erwin G
Paul Hebeisen
Helmut Link
Bbers Thomas L
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO951210D0 publication Critical patent/NO951210D0/no
Publication of NO951210L publication Critical patent/NO951210L/no
Publication of NO304024B1 publication Critical patent/NO304024B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D291/00Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO951210A 1994-03-30 1995-03-29 Nye mono- og bicykliske DNA-gyraseinhibitorer NO304024B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94104995 1994-03-30
EP95101595 1995-02-07

Publications (3)

Publication Number Publication Date
NO951210D0 NO951210D0 (no) 1995-03-29
NO951210L NO951210L (no) 1995-10-02
NO304024B1 true NO304024B1 (no) 1998-10-12

Family

ID=26135552

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951210A NO304024B1 (no) 1994-03-30 1995-03-29 Nye mono- og bicykliske DNA-gyraseinhibitorer

Country Status (15)

Country Link
US (3) US5589473A (fr)
EP (1) EP0675122A3 (fr)
JP (1) JP2695132B2 (fr)
KR (1) KR950032185A (fr)
CN (2) CN1114648A (fr)
AU (1) AU694936B2 (fr)
CA (1) CA2144499A1 (fr)
CZ (1) CZ78895A3 (fr)
FI (1) FI951514A7 (fr)
HU (1) HUT72491A (fr)
IL (1) IL113123A (fr)
NO (1) NO304024B1 (fr)
NZ (1) NZ270801A (fr)
RU (1) RU95104899A (fr)
TW (1) TW343965B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US5922883A (en) * 1996-04-03 1999-07-13 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP4101846B1 (fr) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. Composés d'acide benzoïque 1,2,4-oxadiazole et leur utilisation pour la suppression non-sens et le traitement de maladies
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds
FR2866887A1 (fr) * 2004-02-27 2005-09-02 Oreal Para-phenylenediamine secondaire n-heteroaryle, compositon tinctoriale comprenant une telle para-phenylenediamine, procede mettant en oeuvre cette composition et utilisation
US7329288B2 (en) 2004-02-27 2008-02-12 L'oreal S.A. N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
GB0500683D0 (en) 2005-01-13 2005-02-23 Novartis Ag Organic compounds
WO2006078576A2 (fr) * 2005-01-19 2006-07-27 Merck & Co., Inc. Inhibiteurs de la $g(b)-secretase d'aminomethyle dans le traitement de la maladie d'alzheimer
NZ562034A (en) * 2005-03-31 2009-10-30 Janssen Pharmaceutica Nv Bicyclic pyrazole compounds as antibacterial agents
EP2387995A1 (fr) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Procédés pour la production d'une protéine fonctionnelle à partir d'ADN ayant une mutation non-sens et traitement de troubles associés
US7829709B1 (en) * 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
WO2009100431A1 (fr) * 2008-02-07 2009-08-13 Marquette University Pro-médicaments de cystéine et de cystine pour traiter la schizophrénie et réduire les addictions aux médicaments
CA2721433A1 (fr) * 2008-04-16 2009-11-12 Marquette University Bioisosteres de la cysteine et de la cystine destines a traiter la schizophrenie et a soulager les etats de manque
EP2603080A4 (fr) * 2010-08-12 2014-01-22 Enanta Pharm Inc Inhibiteurs du virus de l'hépatite c
KR101604119B1 (ko) * 2011-06-14 2016-03-16 주식회사 녹십자 신규한 c-아릴 안사 sglt2 억제제
NZ714283A (en) 2013-05-10 2020-04-24 Karus Therapeutics Ltd Novel histone deacetylase inhibitors
TWI695717B (zh) 2014-03-06 2020-06-11 美商 Ptc 治療公司 1,2,4-二唑苯甲酸之鹽及醫藥組合物
GB201419228D0 (en) * 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69211637T2 (de) * 1991-04-17 1997-01-30 Hoffmann La Roche Neue dna-gyrase inhibitoren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
US5665746A (en) 1997-09-09
JP2695132B2 (ja) 1997-12-24
IL113123A (en) 1999-11-30
US5594135A (en) 1997-01-14
EP0675122A3 (fr) 1997-11-05
HU9500860D0 (en) 1995-05-29
AU694936B2 (en) 1998-08-06
NO951210D0 (no) 1995-03-29
EP0675122A2 (fr) 1995-10-04
FI951514A0 (fi) 1995-03-30
FI951514A7 (fi) 1995-10-01
NZ270801A (en) 1997-01-29
JPH07285953A (ja) 1995-10-31
IL113123A0 (en) 1995-06-29
US5589473A (en) 1996-12-31
CN1308071A (zh) 2001-08-15
NO951210L (no) 1995-10-02
HUT72491A (en) 1996-05-28
CN1114648A (zh) 1996-01-10
AU1507095A (en) 1995-10-12
TW343965B (en) 1998-11-01
CA2144499A1 (fr) 1995-10-01
RU95104899A (ru) 1997-01-10
CZ78895A3 (en) 1995-12-13
KR950032185A (ko) 1995-12-20

Similar Documents

Publication Publication Date Title
NO951210L (no) Nye mono- og bicykliske DNA-gyraseinhibitorer
FI972967L (fi) Imidatso(4,5-c)kinoliiniamiineja
DE69626758D1 (de) Werkstückdrehtisch
NO975655D0 (no) Sentreringsenhet
DE59510981D1 (de) Bohrfutter
DE69612854D1 (de) Spannfutter
DK0566751T3 (da) DNA-påvisningsmetode
DE59510926D1 (de) Bohrfutter
DE19581725T1 (de) Spannfutter
ATE253427T1 (de) Werkzeughalter
DE69528980D1 (de) Bohrfutter
DE69602321D1 (de) Spindelvorrichtung
FI963294L (fi) Naftyyliamidit keskushermostoaineina
FI954991A7 (fi) Bisyklisiä tetrahydropyrazolopyridiinejä
NO964095D0 (no) Nye hydroksypyridinoner
DE59812731D1 (de) Vorrichtung zum gegenseitigen Ausrichten von Körpern
DE69514175D1 (de) Spannfutter
FI935830L (fi) Bisyklisiä amiinijohdannaisia
DE69605071D1 (de) Werkzeughalter
DE59604768D1 (de) Zentriereinrichtung
FI971274A7 (fi) Bisyklisiä N-substituoituja piperidinyylibentsoaattijohdannaisia
DE59601412D1 (de) Werkzeughalter
DE59605587D1 (de) Werkzeughaltevorrichtung
DE59606752D1 (de) Werkzeughalter
IT1285362B1 (it) Dispositivo di filtrazione

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002